{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:59:03Z","timestamp":1790614743408,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06528-5","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:14:13Z","timestamp":1781338453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serenoa Repens\u2013Lycopene\u2013Selenium and Epilobium\u2013Palmitoylethanolamide\u2013Calendula after transperineal prostate biopsy: a tertiary single center experience"],"prefix":"10.1007","volume":"44","author":[{"given":"Paolo","family":"Zaurito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Scilipoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Quarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Viti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cosenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Brancaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Occhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Galdieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Porzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Longoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"6528_CR1","doi-asserted-by":"publisher","unstructured":"Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 update. part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86(2): 148\u201363. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027","DOI":"10.1016\/j.eururo.2024.03.027"},{"issue":"6","key":"6528_CR2","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.eururo.2011.12.058","volume":"61","author":"S Loeb","year":"2012","unstructured":"Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schr\u00f6der FH, Roobol MJ (2012) Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol 61(6):1110\u20131114. https:\/\/doi.org\/10.1016\/j.eururo.2011.12.058","journal-title":"Eur Urol"},{"issue":"6","key":"6528_CR3","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","volume":"64","author":"S Loeb","year":"2013","unstructured":"Loeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64(6):876\u2013892. https:\/\/doi.org\/10.1016\/j.eururo.2013.05.049","journal-title":"Eur Urol"},{"issue":"5","key":"6528_CR4","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","volume":"186","author":"S Loeb","year":"2011","unstructured":"Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2011) Complications after prostate biopsy: data from SEER-Medicare. J Urol 186(5):1830\u20131834. https:\/\/doi.org\/10.1016\/j.juro.2011.06.057","journal-title":"J Urol"},{"issue":"3","key":"6528_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","volume":"71","author":"M Borghesi","year":"2017","unstructured":"Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S et al (2017) Complications After Systematic, Random, and Image-guided Prostate Biopsy. Eur Urol 71(3):353\u2013365. https:\/\/doi.org\/10.1016\/j.eururo.2016.08.004","journal-title":"Eur Urol"},{"issue":"2","key":"6528_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.juro.2017.01.103","volume":"198","author":"MA Liss","year":"2017","unstructured":"Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V et al (2017) An Update of the American Urological Association White Paper on the Prevention and Treatment of the More Common Complications Related to Prostate Biopsy. J Urol 198(2):329\u2013334. https:\/\/doi.org\/10.1016\/j.juro.2017.01.103","journal-title":"J Urol"},{"issue":"12","key":"6528_CR7","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1080\/14740338.2016.1190830","volume":"15","author":"A Russo","year":"2016","unstructured":"Russo A, Capogrosso P, La Croce G, Ventimiglia E, Boeri L, Briganti A et al (2016) Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Expert Opin Drug Saf 15(12):1661\u20131670. https:\/\/doi.org\/10.1080\/14740338.2016.1190830","journal-title":"Expert Opin Drug Saf"},{"key":"6528_CR8","doi-asserted-by":"publisher","unstructured":"De Nunzio C, Salonia A, Gacci M, Ficarra V (2022) The role of combination therapy with \u03b1-blockers and hexanic extract of serenoa repens in the treatment of LUTS\/BPH. J Clin Med 11(23). https:\/\/doi.org\/10.3390\/jcm11237169","DOI":"10.3390\/jcm11237169"},{"issue":"15","key":"6528_CR9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/pros.22866","volume":"74","author":"G Morgia","year":"2014","unstructured":"Morgia G, Russo GI, Voce S, Palmieri F, Gentile M, Giannantoni A et al (2014) Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS\/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial). Prostate 74(15):1471\u201380. https:\/\/doi.org\/10.1002\/pros.22866","journal-title":"Prostate"},{"issue":"2","key":"6528_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4081\/aiua.2017.2.110","volume":"89","author":"G Morgia","year":"2017","unstructured":"Morgia G, Russo GI, Urz\u00ec D, Privitera S, Castelli T, Favilla V et al (2017) A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis\/chronic pelvic pain syndrome type III. Arch Ital Urol Androl 89(2):110\u2013113. https:\/\/doi.org\/10.4081\/aiua.2017.2.110","journal-title":"Arch Ital Urol Androl"},{"key":"6528_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2018.11.045","volume":"232","author":"L Deng","year":"2019","unstructured":"Deng L, Zong W, Tao X, Liu S, Feng Z, Lin Y et al (2019) Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L. J Ethnopharmacol 232:1\u201310. https:\/\/doi.org\/10.1016\/j.jep.2018.11.045","journal-title":"J Ethnopharmacol"},{"key":"6528_CR12","doi-asserted-by":"publisher","unstructured":"Cicero AFG, Allkanjari O, Busetto GM, Cai T, Largan\u00e0 G, Magri V, et al (2019) Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Arch Ital Urol Androl 91(3). https:\/\/doi.org\/10.4081\/aiua.2019.3.139","DOI":"10.4081\/aiua.2019.3.139"},{"issue":"2","key":"6528_CR13","doi-asserted-by":"publisher","first-page":"38934521","DOI":"10.4081\/aiua.2024.12582","volume":"96","author":"G Morgia","year":"2024","unstructured":"Morgia G, Lo Giudice A, Carrino M, Voce S, Cocci A, Reale Gea et al (2024) Efficacy of Palmitoylethanolamide, Epilobium and Calendula suppositories for the treatment of patients with chronic prostatitis\/chronic pelvic pain syndrome type III. Arch Ital Urol Androl 96(2):38934521\u201312582. https:\/\/doi.org\/10.4081\/aiua.2024.12582","journal-title":"Arch Ital Urol Androl"},{"issue":"3","key":"6528_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76(3):340\u201351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033","journal-title":"Eur Urol"},{"key":"6528_CR15","unstructured":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG-Guidelines-on-Prostate-Cancer-2026_2026\u201303\u201314\u2013104356"},{"issue":"11","key":"6528_CR16","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00345-015-1525-4","volume":"33","author":"S Tewes","year":"2015","unstructured":"Tewes S, Hueper K, Hartung D, Imkamp F, Herrmann TRW, Weidemann Jea et al (2015) Targeted MRI\/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results. World J Urol 33(11):1707\u20131714. https:\/\/doi.org\/10.1007\/s00345-015-1525-4","journal-title":"World J Urol"},{"issue":"5","key":"6528_CR17","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/s0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, Fowler FJ, O\u2019Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK et al (1992) The American Urological Association symptom index for benign prostatic hyperplasia. The measurement committee of the American urological association. J Urol 148(5):1549\u201357. https:\/\/doi.org\/10.1016\/s0022-5347(17)36966-5","journal-title":"J Urol"},{"issue":"6","key":"6528_CR18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/s0090-4295(97)00238-0","volume":"49","author":"RC Rosen","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49(6):822\u2013830. https:\/\/doi.org\/10.1016\/s0090-4295(97)00238-0","journal-title":"Urology"},{"key":"6528_CR19","unstructured":"R Core Team (2022) R: A language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria.\u00a0 https:\/\/www.R-project.org\/. Accessed March 25 Mar 2024.\u00a0"},{"key":"6528_CR20","doi-asserted-by":"publisher","first-page":"40777606","DOI":"10.3389\/fruro.2025.1565240","volume":"5","author":"G Morgia","year":"2025","unstructured":"Morgia G, Lo Giudice A, Cimino S, Reale G, Largan\u00e0 G, La Manna Eea et al (2025) Comparison of Serenoa repens, lycopene, and selenium versus dutasteride for the treatment of LUTS\/BPH: an Italian multicenter case-control prospective study (COMP study). Frontiers in Urology 5:40777606, 1565240. https:\/\/doi.org\/10.3389\/fruro.2025.1565240","journal-title":"Frontiers in Urology"},{"issue":"21","key":"6528_CR21","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.1073\/pnas.0508218103","volume":"103","author":"V Diwadkar-Navsariwala","year":"2006","unstructured":"Diwadkar-Navsariwala V, Prins GS, Swanson SM, Birch LA, Ray VH, Hedayat S et al (2006) Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A 103(21):8179\u20138184. https:\/\/doi.org\/10.1073\/pnas.0508218103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6528_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/01635580802398430","volume":"61","author":"NO Kanda\u015f","year":"2009","unstructured":"Kanda\u015f NO, Randolph C, Bosland MC (2009) Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations. Nutr Cancer 61(2):251\u2013264. https:\/\/doi.org\/10.1080\/01635580802398430","journal-title":"Nutr Cancer"},{"issue":"11","key":"6528_CR23","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1093\/jn\/133.11.3356","volume":"133","author":"UC Oberm\u00fcller-Jevic","year":"2003","unstructured":"Oberm\u00fcller-Jevic UC, Olano-Martin E, Corbacho AM, Eiserich JP, van der Vliet A, Valacchi G et al (2003) Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J Nutr 133(11):3356\u20133360. https:\/\/doi.org\/10.1093\/jn\/133.11.3356. (PubMed PMID: 14608044)","journal-title":"J Nutr"},{"issue":"1","key":"6528_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/jn\/138.1.49","volume":"138","author":"S Schwarz","year":"2008","unstructured":"Schwarz S, Oberm\u00fcller-Jevic UC, Hellmis E, Koch W, Jacobi G, Biesalski HK (2008) Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J Nutr 138(1):49\u201353. https:\/\/doi.org\/10.1093\/jn\/138.1.49","journal-title":"J Nutr"},{"issue":"2","key":"6528_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.eururo.2023.04.008","volume":"84","author":"S Gravas","year":"2023","unstructured":"Gravas S, Gacci M, Gratzke C, Herrmann TRW, Karavitakis M, Kyriazis Iea et al (2023) Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms. Eur Urol 84(2):207\u2013222. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.008","journal-title":"Eur Urol"},{"issue":"2","key":"6528_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/pros.70071","volume":"86","author":"G Bevilacqua","year":"2026","unstructured":"Bevilacqua G, Carino D, Salciccia S, Gentilucci A, Forte F, Di MM et al (2026) Efficacy of serenoa repens extract combined with alfuzosin versus alfuzosin alone in men with lower urinary tract symptoms due to benign prostatic hyperplasia: a multicenter randomized study. Prostate 86(2):204\u2013218. https:\/\/doi.org\/10.1002\/pros.70071","journal-title":"Prostate"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06528-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06528-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06528-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T08:14:16Z","timestamp":1781338456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06528-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6528"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06528-5","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"422"}}